Michael L. Beshiri

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

Fatima Karzai, David James VanderWeele, Ravi A. Madan et al. · Journal for ImmunoTherapy of Cancer · 2018 · 312 citations · Full text

Medicine, Oncology, Pharmacology +17

A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening

Michael L. Beshiri, Caitlin M. Tice, Crystal Tran et al. · Clinical Cancer Research · 2018 · 228 citations · Full text

Medicine, Oncology, Translational Sciences +15

EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis

Lechen Li, Amir H. Ameri, Simeng Wang et al. · Oncogene · 2019 · 172 citations

Medicine, Cell Biology, Oncology +14

Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking <i>Rb1</i> or <i>Men1</i>

Wenchu Lin, Jian Cao, Jiayun Liu et al. · Proceedings of the National Academy of Sciences · 2011 · 168 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiation

Michael L. Beshiri, Katherine B. Holmes, William F. Richter et al. · Proceedings of the National Academy of Sciences · 2012 · 83 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +17